2Leppik L. Co-ordination of pensions in the European Union: The case of mandatory defined-contribution schemes in the Central and Eastern European countries. Eur J Soc Secur 2006; 8: 35–55.
3Leppik L. Experiences with international social security conventions: A point of view from Central and Eastern European states. In Pennings F (ed), International social security standards: Current views and interpretation matters. Tilburg: Intersentia, 2007: pp. 80–92.
4Saks K, Oja K, Kivisaar S. Marginaliseerumise riski vähendamine eakatel: pensionisüsteem, tervishoiuteenused, sotsiaalteenused. Olukorra kirjeldus Eestis 2003.a [Reduction of the risk of marginalization in older people: Pension system, health and social care services. State of the Art in Estonia 2003], Tartu, 2004: p. 52.
5Saks K, Tiit EM, Muurinen S, Mukkila S, Frommelt M, Hammond M. Quality of life in institutional care. In Vaarama M, Pieper R, Sixsmith R (eds), Care-related quality of life in old age: Concepts, models, and empirical findings. New York: Springer, 2008: pp. 196–216.
6Tulva T. Eakate aktiivsest eluhoiakust [Active attitude in old age]. Sotsiaaltöö [Social Work] 2005; 6: 58–59.
7Tulva T. Ageing in Estonia and challenges for professional growth. In Saari S and Varis T (eds), Ammatillinen kasvu [Professional growth]. Keuruu: Otavan Kirjapaino OY, 2007: 448–56.
8Saks K, Kolk H, Soots A et al. Health status of the older population in Estonia. Croat Med J 2001; 42: 663–68.
9Saks K, Tiit E, Käärik E, Jaanson K. Depressive symptoms in older Estonians: Prevalence and models. J Am Geriatr Soc 2002; 50: 1164–65.
10Saks K, Kolk H, Soots A, Takker U, Vask M. Prevalence of cardiovascular disorders among the elderly in primary care in Estonia. Scand J Prim Health Care 2003; 21: 106–9.
11Haviko T, Maasalu K, Seeder J. The incidence of osteoporotic fractures at the University Hospital of Tartu, Estonia. Scand J Rheumatol 1996; s103: 13–15.
12Haviko T, Kirjanen K, Martson A, Parv M. Total hip arthroplasty: Clinical results. J Bone Joint Surg Br 2004; s3: 250.
13Kõrv J, Roose M. Stroke epidemiology in Estonia. Atherosclerosis Suppl 2004; 5: 32–33.
14Linnamägi Ü, Asser T. Dementne inimene, koormus ühiskonnale [Persons with dementia–burden for the society]. Eesti Arst [Estonian Physician] 2004; 83: 256–61.
15Taba P, Asser T. Incidence of Parkinson's disease in Estonia. Neuroepidemiology 2003; 22: 41–45.
16Taba P, Kanarik E, Krikmann Ü et al. Cognitive behavioural education programme for Parkinsonian patients and carers. J Neurol Sci 2005; 238: S372.
17Häkkinen K, Pakarinen . Muscle strength and serum testosterone, cortisol and SHBG concentrations in middle-aged and elderly men and women. Acta Physiol Scand 1993; 148: 199–207.
18Pääsuke M, Ereline J, Gapeyeva H, Sirkel S, Sander P. Age-related differences in twitch contractile properties of plantarflexor muscles in women. Acta Physiol Scand 2000; 170: 51–57.
19Pääsuke M, Ereline J, Gapeyeva H, Maamägi H. Comparison of twitch-contractile properties of plantar-flexor muscles in young and 52- to 63-year-old men. J Aging Phys Activ 2002; 10: 160–8.
20Kuu S, Gapeyeva H, Ereline J, Pääsuke M. Twitch contractile properties of plantarflexor muscles in young and middle-aged recreationally physically active and non-active women. Aging Clin Exp Res 2009; 19: 48–54.
21Pääsuke M, Ereline J, Gapeyeva H. Age-related differences in knee extension rate of isometric force development and vertical jumping performance in women. J Sports Med Phys Fitness 2003; 43: 453–58.
22Pääsuke M, Ereline J, Gapeyeva H, Joost K, Mõttus K, Taba P. Leg-extension strength and chair-rise performance in elderly women with Parkinson's disease. J Aging Phys Activ 2004; 12: 511–24.
23Schalow G, Pääsuke M, Ereline J, Gapeyeva H. Co-ordination dynamics in Parkinson's disease patients and healthy subjects quantified by the co-ordination dynamic recording method and sEMG. Electromyogr Clin Neurophysiol 2003; 43: 473–85.
24Schalow G, Pääsuke M, Jaigma P. Integrative re-organization mechanism for reducing tremor in Parkinson's disease patients. Electromyogr Clin Neurophysiol 2005; 45: 407–15.
25Jürimäe J, Jürimäe T. Plasma adiponectin concentration in healthy pre- and postmenopüausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab 2007; 293: E42–47.
26Jürimäe J, Kums T, Jürimäe T. Plasma ghrelin concentration is a signal of decreased fat free mass in healthy elderly females. Am J Hum Biol 2009; 21: 404–6.
27Jürimäe J, Kums T, Jürimäe T. Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. Eur J Endocrinol 2009; 160: 381–85.
28Giannakouris K. Ageing characterises the demographic perspectives of the European societies. Population and social conditions Statistics in Focus 72. Eurostat, 2008.
29Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988; 118: 75–86.
30Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14: 885–90.
31Phillips JP, Parkes TL, Hilliker AJ. Targeted neuronal gene expression and longevity in Drosophila. Exp Gerontol 2000; 35: 1157–64.
32Johnson TE, Wood WB. Genetic analysis of life-span in Caenorhabditis elegans. Proc Natl Acad Sci USA 1982; 79: 6603–7.
33Kahn A, Fraga MF. Epigenetics and aging: status, challenges, and needs for the future. J Gerontol A Biol Sci Med Sci 2009; 64: 195–98.
34Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148–59.
35Hjelmborg J, Iachine I, Skytthe A et al. Genetic influence on human lifespan and longevity. Hum Genet 2006; 119: 312–21.
36Hancock DB, Martin ER, Vance JM, Scott WK. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics 2008; 9: 249–62.
37Polonikov AV, Ivanov VP, Solodilova MA. Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene–gene and gene–environment interactions for disease susceptibility. J Hum Genet 2009; 54: 440–49.
38Hitt R, Young-Xu Y, Silver M, Perls T. Centenarians: the older you get, the healthier you have been. Lancet 1999; 354: 652.
39Lin SJ, Kaeberlein M, Andalis AA et al. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 2002; 418: 344–48.
40Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273: 59–63.
41Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004; 36: 512–17.
42Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945–59.
43Lao O, Lu TT, Nothnagel M et al. Correlation between genetic and geographic structure in Europe. Curr Biol 2008; 18: 1241–48.
44Nelis M, Esko T, Mägi R et al. Genetic structure of Europeans: a view from the North-East. PLoS One 2009; 4: e5472.
45Novembre J, Johnson T, Bryc K et al. Genes mirror geography within Europe. Nature 2008; 456: 98–101.
46Choi BG, McLaughlin MA. Why men's hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am 2007; 36: 365–77.
47Andersen K, Launer LJ, Dewey ME et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999; 53: 1992–97.
48Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care. Arch Gen Psychiatry 1998; 55: 405–13.
49Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 2003; 60: 565–71.
50Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry 2004; 75: 637–39.
51Hindorff LA, Sethupathy P, Junkins HA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362–67.
52Novelli V, Viviani Anselmi C et al. Lack of replication of genetic associations with human longevity. Biogerontology 2008; 9: 85–92.
53Smith JD. Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev 2002; 1: 345–65.
54Anselmi CV, Malovini A, Roncarati R et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res 2009; 12: 95–104.
55Flachsbart F, Caliebe A, Kleindorp R et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci USA 2009; 106: 2700–5.
56Li Y, Wang WJ, Cao H et al. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum Mol Genet 2009; 18: 4897–904.
57Willcox BJ, Donlon TA, He Q et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci USA 2008; 105: 13987–92.